The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Autier, Valerie
    Ceo Metabrain Research born in April 1967
    Individual (1 offspring)
    Officer
    2016-08-23 ~ dissolved
    OF - Director → CIF 0
  • 2
    19 Avenue Du Professeur, Cadiot 94700, Maisons Alf, Avenue Du Professeur, Maisons Alfort, Cadiot, France
    Corporate (1 offspring)
    Person with significant control
    2020-11-20 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 8
  • 1
    Mariggi, Giovanni, Dr
    Investor born in February 1985
    Individual (8 offsprings)
    Officer
    2017-02-21 ~ 2019-04-17
    OF - Director → CIF 0
  • 2
    Moreau, Alexandre
    Ceo born in August 1963
    Individual
    Officer
    2017-02-01 ~ 2018-05-31
    OF - Director → CIF 0
  • 3
    Ollier, Michele
    Partner At Medicxi Ventures born in June 1958
    Individual (7 offsprings)
    Officer
    2016-05-23 ~ 2020-11-20
    OF - Director → CIF 0
  • 4
    Valérie Autier
    Born in April 1967
    Individual
    Person with significant control
    2016-08-23 ~ 2016-08-23
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 5
    Narquizian, Robert, Dr
    Company Director born in November 1972
    Individual
    Officer
    2020-11-20 ~ 2023-03-01
    OF - Director → CIF 0
  • 6
    Mizrahi, Jacques, Dr
    Company Director born in September 1954
    Individual
    Officer
    2020-11-20 ~ 2023-03-01
    OF - Director → CIF 0
  • 7
    44, The Esplanade, Jersey, Jersey
    Corporate
    Person with significant control
    2016-08-30 ~ 2020-11-20
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
  • 8
    TCPI ASSET 1 LIMITED - 2013-04-10
    Bridge House, Fiddle Bridge Lane, Hatfield, Hertfordshire, England
    Active Corporate (4 parents, 32 offsprings)
    Equity (Company account)
    805,306 GBP2018-04-30
    Officer
    2016-05-23 ~ 2023-07-31
    PE - Secretary → CIF 0
parent relation
Company in focus

KYMO THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02020-06-01 ~ 2021-05-31
02019-06-01 ~ 2020-05-31
Fixed Assets - Investments
8,391 GBP2021-05-31
8,391 GBP2020-05-31
Debtors
7,007 GBP2021-05-31
22,809 GBP2020-05-31
Cash at bank and in hand
520 GBP2021-05-31
45,492 GBP2020-05-31
Current Assets
7,527 GBP2021-05-31
68,301 GBP2020-05-31
Creditors
Current
31,417 GBP2021-05-31
8,952 GBP2020-05-31
Net Current Assets/Liabilities
-23,890 GBP2021-05-31
59,349 GBP2020-05-31
Total Assets Less Current Liabilities
-15,499 GBP2021-05-31
67,740 GBP2020-05-31
Equity
Called up share capital
12,993 GBP2021-05-31
12,993 GBP2020-05-31
Share premium
1,150,639 GBP2021-05-31
1,150,639 GBP2020-05-31
Retained earnings (accumulated losses)
-1,179,131 GBP2021-05-31
-1,095,892 GBP2020-05-31
Equity
-15,499 GBP2021-05-31
67,740 GBP2020-05-31
Investments in Group Undertakings
Cost valuation
8,391 GBP2020-05-31
Investments in Group Undertakings
8,391 GBP2021-05-31
8,391 GBP2020-05-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
414 GBP2021-05-31
15,014 GBP2020-05-31
Other Debtors
Current, Amounts falling due within one year
6,593 GBP2021-05-31
7,795 GBP2020-05-31
Debtors
Current, Amounts falling due within one year
7,007 GBP2021-05-31
22,809 GBP2020-05-31
Trade Creditors/Trade Payables
Current
30,166 GBP2021-05-31
7,700 GBP2020-05-31
Other Creditors
Current
1,251 GBP2021-05-31
1,252 GBP2020-05-31
Profit/Loss
Retained earnings (accumulated losses)
-83,239 GBP2020-06-01 ~ 2021-05-31
Profit/Loss
-83,239 GBP2020-06-01 ~ 2021-05-31

  • KYMO THERAPEUTICS LIMITED
    Info
    Registered number 10194104
    C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge CB22 3FH
    Private Limited Company incorporated on 2016-05-23 and dissolved on 2024-07-16 (8 years 1 month). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.